Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05681481 |
|---|---|
| Brief Title: | A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid (BALLAD+) |
| First Submitted : | December 8, 2022 |
| First Submitted that Met QC Criteria : | December 27, 2022 |
| First Posted : | January 12, 2023 |
| Last Update Submitted that Met QC Criteria : | April 7, 2024 |
| Last Update Posted : | April 9, 2024 |